A Study to Compare the Efficacy and Safety of Obinutuzumab + Venetoclax versus Obinutuzumab + Chlorambucil in Patients With Chronic Lymphocytic Leukemia (CLL14)
暂无分享，去创建一个
Seunghyeon Shin | Kyoungjune Pak | D. Park | J. Behravan | K. Abnous | M. Hallek | S. Stilgenbauer | D. Mertens | N. Zhang | H. Reinhardt | C. Pallasch | L. Frenzel | Morteza Ghandadi | Xiequn Chen | Zhe Wang | F. Mosaffa | P. Langerbeins | C. Herling | E. Tausch | P. Cramer | B. Eichhorst | Baoxia Dong | G. Gao | R. Liang | H. Gu | C. Hao | Q. Bai | Carolin Groß-Ophoff-Müller | Mi-Mi Shu | Seong Jang Kim | Lan Yang | Tao Zhang